20 LATEST RESOURCES (218 INDEXED)
Efficacy and Safety of Agomelatine versus SSRIs/SNRIs for Post-Stroke Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · October 2023
Abstracts
International Clinical Psychopharmacology
A Comparative Study of the Efficacy of Venlafaxine and Naltrexone for Relapse Prevention in Patients with Opioid Use Disorder Attributed to Tramadol · September 2023
Abstracts
International Clinical Psychopharmacology
Does Celecoxib with Sodium Valproate Have an Augmentation Effect on Acute Mania in Bipolar Disorder? A Double-Blind Controlled Clinical Trial in Iran · September 2023
Abstracts
International Clinical Psychopharmacology
Cariprazine: An Augmentation Strategy for Treatment-Resistant Schizophrenia with Pro-Cognitive and Anti-Hostility Effects · September 2023
Abstracts
International Clinical Psychopharmacology
L-Carnitine Adjunct to Risperidone for Treatment of Autism Spectrum Disorder-Associated Behaviors: A Randomized, Double-Blind Clinical Trial · August 2023
Abstracts
International Clinical Psychopharmacology
Long-Term Remission Following Esketamine Nasal Spray Sessions in a Patient with Severe and Highly Treatment-Resistant Depression: A Single-Case Report · July 2023
Abstracts
International Clinical Psychopharmacology
Cilostazol as Adjunctive Therapy in Treatment of Children with Autism Spectrum Disorders: A Double-Blind and Placebo-Controlled Randomized Trial · March 2023
Abstracts
International Clinical Psychopharmacology
Early versus Late Administration of Long-Acting Injectable Antipsychotic Agents among Patients with Newly Diagnosed Schizophrenia: An Analysis of a Commercial Claims Database · February 2023
Articles
International Clinical Psychopharmacology
The Effect of Crocin versus Sertraline in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial · January 2023
Abstracts
International Clinical Psychopharmacology
Is Mirtazapine Augmentation Effective for Patients with Obsessive-Compulsive Disorder Who Failed to Respond to Sertraline Monotherapy? A Placebo-Controlled, Double-Blind, Clinical Trial · January 2023
Abstracts
International Clinical Psychopharmacology
Systematic Literature Review and Network Meta-Analysis of Lurasidone, Brexpiprazole and Cariprazine for Schizophrenia · January 2023
Abstracts
International Clinical Psychopharmacology
Patterns of Antipsychotic Prescription and Accelerometer-Based Physical Activity Levels in People with Schizophrenia Spectrum Disorders: A Multicenter, Prospective Study · January 2023
Articles
International Clinical Psychopharmacology
Acceptability of Transdermal Antipsychotic Patches by Patients Who Refuse Oral Medication and Their Effectiveness in Preventing Recurrence of Delirium: A Retrospective Observational Study · January 2023
Articles
International Clinical Psychopharmacology
Clinical Correlates and Prognostic Impact of Binge-Eating Symptoms in Major Depressive Disorder · November 2022
Articles
International Clinical Psychopharmacology
The Dilemma of Polypharmacy in Psychosis: Is It Worth Combining Partial and Full Dopamine Modulation? · November 2022
Articles
International Clinical Psychopharmacology
Repeated Subcutaneous Racemic Ketamine in Treatment-Resistant Depression: Case Series · September 2022
Articles
International Clinical Psychopharmacology
A 1-Year, Double-Blind, Placebo-Controlled Trial of Ziprasidone 40, 80 and 160 Mg/Day in Chronic Schizophrenia: The Ziprasidone Extended Use in Schizophrenia (ZEUS) Study · September 2022
Abstracts
International Clinical Psychopharmacology
Persistence of Suicidal Ideation within Acute Phase Treatment of Major Depressive Disorder: Analysis of Clinical Predictors · September 2022
Articles
International Clinical Psychopharmacology
Can Levetiracetam Improve Clinical Symptoms in Schizophrenic Patients? A Randomized Placebo-Controlled Clinical Trial · July 2022
Abstracts
International Clinical Psychopharmacology
Medicare Claims Analysis of Agents Used to Manage Dementia-Related Psychosis: A Treatment Pattern Study · May 2022
Articles
International Clinical Psychopharmacology